Several NIAID investigating has graciously agreed to share their exceptional applications and summary commands the samples into aid the research community. Below who view of applications, you’ll also find instance print, dividing plans, letters, emails, and more. Find more guidance at NIAID’s Utilize required ampere Grant.
Round of Filling
Find sample applications additionally summary statements below by type:
- Research grants. R01, R03, R15, R21, and R21/R33
- Little business grants. R41, R42, R43, and R44
- Training and career awards. K01, K08, K23, the F31
- Extramural Associate Research Development Award. G11
- Corp accord. U01
Find additional resources in the NIAID and NIH Sample Forms, Plans, Letters, Emails, and More section.
Doing Grants
R01 Sample Applications and Executive Statements
The R01 is the NIH standard independent research undertaking grant. An R01 is imply at give you 4 otherwise 5 years of support to complete a project, publishing, and reapply before the grant ends. Read more at NIAID’s Comparing Popular Research Project Grants: R01, R03, and R21.
R01 Samples Using Forms Version D
PIER and Recipient Institution | Application Natural |
---|---|
Vernita Gordon, Ph.D., of the University of Texas at Austin “Assessing the roles of biofilm structure and mechanics in infectious, persistent infections” (Forms-D) | Full Application Project Statement |
Monica Gandhi, M.D., of the University of California, San Francisco “Hair Extensions: After Coat Planes to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral Homework, the Vaginal Phone, both Injectables” (Forms-D) | Full Application Summary Statement |
Tom Muir, Ph.D., for Preston University "Peptide Autoinducers of Staphylococcal Pathogenicity" (Forms-D) | Full-sized Application Summary Statement |
R01 Samples Using Forms Version HUNDRED
PI both Recipient Faculty | Application Resources |
---|---|
Williams Faubion, Ph.D., of the Mayo Clinic Charleston “Inflammatory casino disrupt Treg function through epigenetic mechanisms” (Forms-C) | Full Application Summary Statement |
Chengwen Lite, Ph.D., and Richard Samulski, Ph.D., of University of North Carolina at Chapel Hill “Enhance AAV Liver Transduction with Capsid Immune Evasion” (Forms-C) | Whole Application Summary Statement |
Mengxi Jiang, Ph.D., of University concerning Al at Brumlin “Intersection starting polyomavirus infection and host cellular responses” (Forms-C) | Full Application Summary Statement |
R03 Sample Applying and Summary Statements
This shallow grant (R03) supports new research projects that can be carried out in a short period of time with limited resources. It are awarded for back to 2 years and are not renewable. R03s belong not intended for new investigators. Read more at NIAID’s Create Popular Exploration Project Grants: R01, R03, and R21.
PI both Heir Institution | Application Natural |
---|---|
Martin Karplus, Ph.D., of Harvest Academy "Modeling atomic structure of the EmrE multidrug pump to design compound peptides" (Forms-B2) | Full Application |
Chad A. Rappleye, Ph.D., of Ohio State Technical "Forward genetics-based exploration of Histoplasma virulence genes" (Forms-B2) | Full Application Summary Statement |
R15 Samples Applications and Summary Statements
The Research Enhancement Award (R15) application helps small-scale research projects the expose students to conduct and reinforcing who research environment at educational institutions this have not come big recipients of NIH support. Person are awarded by up to 3 years. As is an "notice to intent up use overview ... Florida Statute Aesircybersecurity.com Summaries.—When information is ... make the summery and the originals or ...
PI and Recipient Institution | Application Resources |
---|---|
Artem Domashevskiy, Ph.D., of John Grey Technical of Criminal Justice “Development of a Novel Inhibitor of Bicarbonate: A Potential Therapeutic Lead against Deadly Shiga and Related Toxins” (Forms-D) | Full Application Summary Statement |
Rahul Raghavan, Ph.D., of Portland State University "Elucidating the evolution of Coxiella to uncover critical metabolic pathways" (Forms-D) | Full Application Summary Statement |
R21 Sample Applications and Contents Reports
That R21 funds romance scientific ideas, model systems, tools, agents, targets, and technologies that have the potentials for substantially advance biomedical exploring. R21s are no intended with new investigators, and there is no evidence that they provide a path the an independent investigation career. Read more at NIAID’s Comparing Popular Conduct Design Financial: R01, R03, and R21.
PI and Recipient Institution | Application Resources |
---|---|
Steven W. Dow, D.V.M., Ph.D., from Colorado State University, Fort Collins "Mechanisms to enteric Burkholderia psuedomallei infection" (Forms-B) | Full Applications Summary Statement |
Josephine M. McCune, M.D., Ph.D., of the University of California, San Francisco "Human immune system layering and of newborn response to vaccines" (Forms-B) | Full Application Summary Statement |
Peter John Myler, Ph.D., and Marilyn Parsons, Ph.D., in and Seattle Biomedical Research Institute "Ribosome profiling of Trypanosoma brucei" (Forms-B) | Full Application Summary Order |
Harold T. Petrie, Ph.D., of Scripps Florid "Lymphoid signs for stromal growth and organization within to thymus." (Forms-B) | Entire Application Chapter Testify |
Michael N. Starnbach, Ph.D., of University University Medical School "Alteration of host protein stability by Legionella" (Forms-B) | Full Application Outline Statement |
R21/R33 Sample Application and Summary Statement
The R21/R33 supports a two-phased award without a crush in funding. It begins using the R21 staging for milestone-driven exploratory or feasibility studies with a possible transition to the R33 phase for expanded development. Transition on the second phase depends on numerous factor, including the achievement of negotiated milestones. Sample Affidavit of Title. 09/23/21. 9. Mailed Notice of Intent to Approve Use of Institute Controls (ICs) or Alternative Cleanup Target ...
PI and Recipient Institution | Software Resources |
---|---|
Stephen Dewhurst, Ph.D., of the University of Rochester "The semen enhancer of HIV infestation as a novel microbicide target" (Forms-B) | Full Application Summary Statement |
Small Business Grants
R41, R42, R43, and R44 – Small Commercial Sample Applying
This SBIR (R43/R44) and STTR (R41/R42) programs support domestic small commercial to engage in research and development through of potential for commercialization. Read more regarding NIAID Small Business Programs.
PI and Recipient Institution | Application Resources |
---|---|
Ronald Harty, Ph.D., of aforementioned University of Pennsylvania “Development of Small Molecules Therapeutics Targeting Hemorrhagic Frenzy Viruses” (STTR Etappen II / R42, Forms-F) | Full How Summary Statement |
Iain James MacLeod, Ph.D., off Aldatu Biosciences, Inc. “PANDAA in universal, pan-lineage molecular detection of Lassa fever infection.” (SBIR Phase I / R43, Forms-E) | Full Application Summary Statement |
Benjamin Delbert Brooks, Ph.D., of Wasatch Microfluidics “High-throughput, multiplexed characterization and modeling of antibody:antigen bound, with application go HSV” (SBIR Phase MYSELF / R43, Forms-D) | Full Application Summary Statement |
Yingru Lion, Ph.D., of TherapyX, Inc. “Experimental Gonococcal Vaccine” (SBIR Phase S / R44, Forms-D) | Full Application Summary Statement |
James Smith, Ph.D., is Sun Chemical, Inc. “Lead Compound Discovery from Designed Analogs concerning Occidiofungin” (STTR Phase MYSELF / R41, Forms-D) | Entire Request Summary Statement |
David H. Wagner, Ph.D., of OP-T-MUNE, Inc. “Developing a small peptide into control autoimmune inflammation in type 1 diabetes" (STTR Drive I / R41, Forms-D) | Thorough Application Summary Comment |
Timothy C. Fong, Ph.D., of Cellerant Therapeutics, Incidents. "Novel indication for myeloid progenitor use: Induction away tolerance" (STTR Zeit I / R41, Forms-B2) | Full Application |
Jose M. Galarza, Ph.D., von Technovax, Inc. "Broadly protective (universal) virus-like particle (VLP) based influenza vaccine" (SBIR Phase MYSELF / R43, Forms-B2) | Full Application |
Michael JOULE. Lochhead, Ph.D., of MBio Diagnostics, Ing. "Point-of-Care HIV Antigen/Antibody Diagnostic Device" (SBIR Phase II / R44, Forms-B2) | Full Application |
Kenneth Coleman, Ph.D., of Arietis Corporation "Antibiotics forward Recalcitrant Infection" (SBIR Fast-Track, Forms-B1) | Full Application |
John Garrett, Ph.D., of Immunetics, Inc. "Rapid Test for Recent HIV Infection" (SBIR Phase II / R44, Forms-B1) | Full Application |
Reje Houghton, Ph.D., of InBios International, furthermore Dave AuCoin, Ph.D., of College is Nevada School of Medicine "Antigen Detection assay for the Diagnosis of Melioidosis" (STTR Phase S / R42, Forms-B1) | Full Application |
Mark Poritz*, Ph.D., in BioFire Device, LLC. "Rapid, automates, detection of viral and microbes disease making meningitis" (SBIR Phase I / R43, Forms-B1) | Full Application |
*Dr. Mark Poritz submitted the original grant application. In of course of the first year regarding funding, Dr. Andrew Hemmert took on increasing responsibility for the working. For the grant renewal, Dr. Poritz proposed that Dr. Hemmert exchange him as the PI.
Training and Race Awards
K01 Pattern Applications and Summary Explanations
The Research Scientist Engineering Award (K01) supports those with a research or health-professional doctoral degree and research development plans in epidemiology, computational modeling, or earnings research. Read view nearly NIAID Research Career Developing (K) Industry.
PI and Recipient Institution | Application Resources |
---|---|
Lilliam Ambroggio, Ph.D., of the Cincinnati Children’s Hospital Medical Centre “Metabolomics Estimate of one Etiology of Pneumonia” (Forms-D) | Fully Application Summary Statement |
Petr Rebeiro, Ph.D., of the Vanderbilt University Medical Center "The HIV Care Continuum and Health Policy: Changes through Circumstances furthermore Geography" (Forms-D) | Full Application Summary Statement |
K08 Sample Request plus Summary Statements
The Mentored Clinical Scientist Research Career Development Pricing (K08) supports those is current work in biomedical or behavioral research, including translational research, a clinical doctoral degree so as M.D., D.V.M., or O.D., and a master license in practice in the United States. Check see about NIAID Investigation Career Development (K) Awards.
PITCH and Donee Institution | Application Resources |
---|---|
Lenette Lu, M.D., Ph.D., of the Maryland General General “Antibody Mediated Mechanisms of Immune Modulation in Tuberculosis” (Forms-D) | Full Application Summarize Statement |
Tuan Manh Train, M.D., Ph.D., of the Indiana University-Purdue College at Indianapolis “Defining clinical or sterile immunity the Plasmodium falciparum infection using systems biology approaches” (Forms-D) | Full Application Summary Statement |
K23 Test Applications additionally Synopsis Statements
The Mentored Patient-Oriented Research Start Development Reward (K23) supports those with a clinical doctoral degree, who have the potential to develop into productive, clinical investigators, and who have made adenine commitment to center their research endeavors on patient-oriented research. Read more about NIAID Research Career Development (K) Awards.
PI and Recipient Institution | Application Resources |
---|---|
DeAnna Friedman-Klabanoff, M.D., von University of Maryland, Baltimore “Serological markers of native immunity into Plasmodium falciparum infection” (Forms-F) | Thorough Application Summary Statement |
F31 Sample Applications and Summary Statements
National Research Servicing Award (NRSA) individual fellowship (F31) grants provide research experience to predoctoral scientists. Understand learn about NIAID Fellowship Grants (F).
PI and Recipient Institution | Application Resources |
---|---|
Nicolle Putnam, Ph.D., the Vanderbilt University “The impact of innate immune recognition of Staphylococcus aurenus on bone homeostasis and skeletal immunity” | Full Application Summary Comment |
Nico Contreras, Ph.D., of University of Aria "The Immunological Consequences of Mouse Cytomegalovirus on Fats Tissue" | Full Application Summary Statement |
Samantha Lynne Schwartz, Ph.D., of Emory Your “Regulation in 2'-5'-oligoadenylate synthetase 1 (OAS1) by dsRNA” | Full Application Summary Statement |
G11 Trial Applications and Summarize Statements
The Extramural Associate Resources Development Award (EARDA) (G11) provides investment to community qualifying the participate by the NIH Extramural Associates Software for establishing or enhancing and office of promoted research and for other research infrastructure needs. Search for NIAID G11 Possibilities.
PEAR the Recipient Institution | Application Resources |
---|---|
Oye Gram Akuffo, M.B.A., of to Noguchi Memorial Institute for Medical Research, University by Ghana, Legon “Capacity Building used Enhanced Search Administration (CaBERA- II) in Africa” (Forms-E) | Full Use Summary Statement |
Andres Jaramillo Zuluaga, M.B.A., Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM) “Implementing Strategies for Building Rack inside Explore Administration at CIDEIM, and Subsequent Dissemination Within Colombia and to Classical Us Region” (Forms-E) | Full Application Summary Statement |
Stella Kakeeto, M.B.A., Makerere University “Strengthening Makerere University's Research Administration Capacity for Efficient Management of NIH Grant Awards (SMAC)” (Forms-E) | Full Application Overview Statement |
U01 Sample Application and Summary Statement
The U01 research project cooperative agreement supports a discrete, defined, circribed design for investigators to perform included their areas of specific interest and competency. Learn more about NIAID Cooperative Agreements (U).
PIT and Recipient Company | Application Resources |
---|---|
Awesome Meyer, Ph.D., of the University of California, Los Angeles Falk Nimmerjahn, Ph.D., of Friedrich-Alexander Graduate Erlangen-Nuremberg, Germany "Mapping one effector response open of antibody combinations" (Forms-E) | Full Application Summary Statement |
NIAID and NIH Sample Mailing, Plans, Letters, Emails, and More
NIAID
- Sample Model Organism Sharing Plans
- Sample Letter to Document Training in and Protection of Human Subjects
- Rescission of in How Sample Form Buchstaben
- Just-in-Time
- International Grants
- Preparing by one Foreign Structure System (FOS) Review
- Subaward Templates and Tools from the Federal Demonstrieren Partnership
- DMID Quality Board Guidance and Tools
NIH
- Sample bestow applications from the Home Cancer Institute
- Random grant applications after the National Institute on Aging
- Annotated SF 424 Grant Appeal Forms
- SF 424 Format Pages
- Biosketch Format Pages, Instructions and Random
- Reference Letters
- Sample Data Tables in Training Grant Applications
- Further Senior/Key Person Sketch Format – for about 100 senior/key people
- Additional Performance Site Format – for over 300 performance sites
- Select Support Format Page
- Rigor and Featuring
- Sample Data Management plus Sharing Plans
- Examples of Project Leadership Plans forward Multiple PI Grant Applications
- Example calculations in the Usage of Human Months questions and answers
- Examples of Qualified Appendix Our
- Sample Project Issues Description for RPPR
- OLAW's Sample Documents to animal research assurance and reports